Inflammatory phenotypes in airway disease

Symposium
Chairs: E. Bel (Amsterdam, The Netherlands), C. Brightling (Leicester, United Kingdom)
Aims: The aim is to review what we know about the importance (or otherwise) of inflammatory phenotypes in asthma and to extend this into other airway diseases such as COPD and chronic cough. This information has not been pulled together before, and has a major impact on clinical practice and how we think about airway diseases.

Epidemiology of eosinophilic and noneosinophilic asthma J. Douwes (Wellington, New Zealand)
Mechanisms of noneosinophilic asthma P. Gibson (Newcastle, Australia)
Prognosis: what is the contribution of inflammation to the decline in lung function in airway disease? J. Vestbo (Hvidovre, Denmark)
Treatment: how does inflammatory phenotype influence response to treatment in airway disease? C. Brightling (Leicester, United Kingdom)